189 related articles for article (PubMed ID: 36586361)
1. Gray to white matter signal ratio as a novel biomarker of neurodegeneration in Alzheimer's disease.
Putcha D; Katsumi Y; Brickhouse M; Flaherty R; Salat DH; Touroutoglou A; Dickerson BC
Neuroimage Clin; 2023; 37():103303. PubMed ID: 36586361
[TBL] [Abstract][Full Text] [Related]
2. Cortical gray to white matter signal intensity ratio as a sign of neurodegeneration and cognition independent of β-amyloid in dementia.
Xu X; Jang I; Zhang J; Zhang M; Wang L; Ye G; Zhao A; Zhang Y; Li B; Liu J; Li B;
Hum Brain Mapp; 2024 Jan; 45(1):e26532. PubMed ID: 38013633
[TBL] [Abstract][Full Text] [Related]
3. Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease.
Spotorno N; Strandberg O; Vis G; Stomrud E; Nilsson M; Hansson O
Brain; 2023 Apr; 146(4):1602-1614. PubMed ID: 36130332
[TBL] [Abstract][Full Text] [Related]
4. White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration.
Kantarci K; Schwarz CG; Reid RI; Przybelski SA; Lesnick TG; Zuk SM; Senjem ML; Gunter JL; Lowe V; Machulda MM; Knopman DS; Petersen RC; Jack CR
JAMA Neurol; 2014 Dec; 71(12):1547-54. PubMed ID: 25347157
[TBL] [Abstract][Full Text] [Related]
5. Detection of gray matter microstructural changes in Alzheimer's disease continuum using fiber orientation.
Lee P; Kim HR; Jeong Y;
BMC Neurol; 2020 Oct; 20(1):362. PubMed ID: 33008321
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
Koychev I; Hofer M; Friedman N
J Nucl Med; 2020 Oct; 61(10):1413-1418. PubMed ID: 32764121
[TBL] [Abstract][Full Text] [Related]
7. White Matter Hyperintensity Volume and Amyloid-PET Synergistically Impact Memory Independent of Tau-PET in Older Adults Without Dementia.
Edwards L; Thomas KR; Weigand AJ; Edmonds EC; Clark AL; Walker KS; Brenner EK; Nation DA; Maillard P; Bondi MW; Bangen KJ;
J Alzheimers Dis; 2023; 94(2):695-707. PubMed ID: 37302031
[TBL] [Abstract][Full Text] [Related]
8. Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer's Disease Continuum.
Iaccarino L; La Joie R; Edwards L; Strom A; Schonhaut DR; Ossenkoppele R; Pham J; Mellinger T; Janabi M; Baker SL; Soleimani-Meigooni D; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
Cereb Cortex; 2021 Jan; 31(1):1-14. PubMed ID: 32808011
[TBL] [Abstract][Full Text] [Related]
9. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
Kim CM; Hwang J; Lee JM; Roh JH; Lee JH; Koh JY;
Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813
[TBL] [Abstract][Full Text] [Related]
10. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
11. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
[TBL] [Abstract][Full Text] [Related]
12. Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease.
Xia C; Makaretz SJ; Caso C; McGinnis S; Gomperts SN; Sepulcre J; Gomez-Isla T; Hyman BT; Schultz A; Vasdev N; Johnson KA; Dickerson BC
JAMA Neurol; 2017 Apr; 74(4):427-436. PubMed ID: 28241163
[TBL] [Abstract][Full Text] [Related]
13. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
14. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
Thal DR; Attems J; Ewers M
J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
[TBL] [Abstract][Full Text] [Related]
15. Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum.
Tosun D; Demir Z; Veitch DP; Weintraub D; Aisen P; Jack CR; Jagust WJ; Petersen RC; Saykin AJ; Shaw LM; Trojanowski JQ; Weiner MW;
Alzheimers Dement; 2022 Jul; 18(7):1370-1382. PubMed ID: 34647694
[TBL] [Abstract][Full Text] [Related]
16. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
17. Association of deposition of tau and amyloid-β proteins with structural connectivity changes in cognitively normal older adults and Alzheimer's disease spectrum patients.
Shigemoto Y; Sone D; Maikusa N; Okamura N; Furumoto S; Kudo Y; Ogawa M; Takano H; Yokoi Y; Sakata M; Tsukamoto T; Kato K; Sato N; Matsuda H
Brain Behav; 2018 Dec; 8(12):e01145. PubMed ID: 30358161
[TBL] [Abstract][Full Text] [Related]
18. Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy.
Putcha D; Brickhouse M; Touroutoglou A; Collins JA; Quimby M; Wong B; Eldaief M; Schultz A; El Fakhri G; Johnson K; Dickerson BC; McGinnis SM
Neuroimage Clin; 2019; 23():101889. PubMed ID: 31200149
[TBL] [Abstract][Full Text] [Related]
19. Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET.
Ottoy J; Ozzoude M; Zukotynski K; Adamo S; Scott C; Gaudet V; Ramirez J; Swardfager W; Cogo-Moreira H; Lam B; Bhan A; Mojiri P; Kang MS; Rabin JS; Kiss A; Strother S; Bocti C; Borrie M; Chertkow H; Frayne R; Hsiung R; Laforce RJ; Noseworthy MD; Prato FS; Sahlas DJ; Smith EE; Kuo PH; Sossi V; Thiel A; Soucy JP; Tardif JC; Black SE; Goubran M;
Alzheimers Dement; 2023 Apr; 19(4):1503-1517. PubMed ID: 36047604
[TBL] [Abstract][Full Text] [Related]
20. Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [
Young CB; Landau SM; Harrison TM; Poston KL; Mormino EC;
Neuroimage; 2021 Nov; 243():118553. PubMed ID: 34487825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
